Clinical Trial Update: Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) [Phase 4]

View source ↗

Summary

Phase 4 trial update on dapagliflozin examining cholesterol metabolism in type 2 diabetes and hypercholesterolemia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Diabetes Mellitus, Type 2, Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2020-08-04